CytoDyn Inc.
General ticker "CYDY" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $309.3M (TTM average)
CytoDyn Inc. follows the US Stock Market performance with the rate: 13.7%.
Estimated limits based on current volatility of 5.6%: low 0.31$, high 0.34$
Factors to consider:
- Total employees count: 12 as of 2023
- Top business risk factors: Cash reserves and financing needs, Operating losses and lack of profitability, Financing risks, Going concern, Inventory write offs
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-05-31 to 2027-05-31
- 2025-05-31 to 2026-05-31 estimated range: [0.14$, 0.43$]
- 2026-05-31 to 2027-05-31 estimated range: [0.09$, 0.29$]
Financial Metrics affecting the CYDY estimates:
- Positive: with PPE of 157.5 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 53.96 > 18.64
- Negative: Operating cash flow per share per price, % of -2.07 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of -532.17 <= 18.93
- Positive: Return on assets ratio (scaled to [-100,100]) of 17.19 > 6.04
- Positive: Investing cash flow per share per price, % of 0 > -0.66
Short-term CYDY quotes
Long-term CYDY plot with estimates
Financial data
| YTD | 2023-05-31 | 2024-05-31 | 2025-05-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $20.98MM |
| Operating Expenses | $40.58MM | $18.06MM | $9.66MM |
| Operating Income | $-40.58MM | $-18.06MM | $11.32MM |
| Non-Operating Income | $-39.25MM | $-31.78MM | $-7.58MM |
| Interest Expense | $39.25MM | $31.78MM | $4.86MM |
| R&D Expense | $2.63MM | $7.24MM | $16.92MM |
| Income(Loss) | $-79.82MM | $-49.84MM | $3.75MM |
| Profit(Loss)* | $-79.82MM | $-49.84MM | $3.75MM |
| Stockholders Equity | $-109.50MM | $-116.76MM | $-96.04MM |
| Assets | $11.29MM | $11.14MM | $18.05MM |
| Operating Cash Flow | $-25.11MM | $-10.98MM | $-8.77MM |
| Financing Cash Flow | $29.93MM | $11.75MM | $10.85MM |
| Earnings Per Share** | $-0.10 | $-0.05 | $0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.